{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:18:13Z","timestamp":1786659493460,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.xphs.2022.12.019","type":"journal-article","created":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T01:15:32Z","timestamp":1671930932000},"page":"2057-2068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-7806","authenticated-orcid":false,"given":"Tze Ning","family":"Hiew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-5191","authenticated-orcid":false,"given":"Sugandha","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-9195","authenticated-orcid":false,"given":"Dmitry Y.","family":"Zemlyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-5111","authenticated-orcid":false,"given":"Ashish","family":"Punia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-6598","authenticated-orcid":false,"given":"Michael","family":"Lowinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5082-1884","authenticated-orcid":false,"given":"Marina A.","family":"Solomos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Schenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-6021","authenticated-orcid":false,"given":"Lynne S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2022.12.019_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/pharmaceutics10040263","article-title":"A comprehensive map of FDA-approved pharmaceutical products","volume":"10","author":"Zhong","year":"2018","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.019_bib0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425247.4.4.403","article-title":"Drug delivery strategies for poorly water-soluble drugs","volume":"4","author":"Fahr","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.019_bib0003","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/acs.cgd.5b01341","article-title":"Supersaturation potential of salt, co-crystal, and amorphous forms of a model weak base","volume":"16","author":"Almeida e Sousa","year":"2016","journal-title":"Cryst Growth Des"},{"issue":"7","key":"10.1016\/j.xphs.2022.12.019_bib0004","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/cg200492w","article-title":"Solubility advantage of amorphous drugs and pharmaceutical cocrystals","volume":"11","author":"Babu","year":"2011","journal-title":"Cryst Growth Des"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.019_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcrysgrow.2016.07.001","article-title":"Spring and parachute: how cocrystals enhance solubility","volume":"62","author":"Bavishi","year":"2016","journal-title":"Prog Cryst Growth Charact Mater"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.019_bib0006","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1208\/s12248-016-9939-5","article-title":"Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion","volume":"18","author":"Gumaste","year":"2016","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.019_bib0007","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11095-022-03183-4","article-title":"Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone","volume":"39","author":"Indulkar","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2022.12.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122120","article-title":"Role of surfactants in improving release from higher drug loading amorphous solid dispersions","volume":"625","author":"Correa-Soto","year":"2022","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11095-021-03159-w","article-title":"Impact of surfactants on the performance of clopidogrel-copovidone amorphous solid dispersions: increased drug loading and stabilization of nanodroplets","volume":"39","author":"Correa Soto","year":"2022","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2017.10.051","article-title":"Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery \u2013 an update","volume":"535","author":"Jermain","year":"2018","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2022.12.019_bib0011","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.10226","article-title":"Self-association and cyclodextrin solubilization of drugs","volume":"91","author":"Loftsson","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.12.019_bib0012","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2016.03.006","article-title":"Physical chemistry of supersaturated solutions and implications for oral absorption","volume":"101","author":"Taylor","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.xphs.2022.12.019_bib0013","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/mp8001073","article-title":"Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug","volume":"5","author":"Lakshman","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2022.12.019_bib0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2019.01.009","article-title":"Building a better particle: leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings","volume":"559","author":"Schenck","year":"2019","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2018.05.008","article-title":"A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products","volume":"545","author":"Kelleher","year":"2018","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2022.12.019_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071034","article-title":"Hierarchical particle approach for co-precipitated amorphous solid dispersions for use in preclinical in vivo studies","volume":"13","author":"Schenck","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.xphs.2022.12.019_bib0017","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1248\/cpb.26.3033","article-title":"Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate","volume":"26","author":"Sekikawa","year":"1978","journal-title":"Chem Pharm Bull"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.019_bib0018","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jps.2600580503","article-title":"Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates","volume":"58","author":"Simonelli","year":"1969","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.12.019_bib0019","article-title":"Coprecipitated amorphous dispersions as drug substance: opportunities and challenges","author":"Strotman","year":"2021","journal-title":"Org Process Res Dev"},{"issue":"10","key":"10.1016\/j.xphs.2022.12.019_bib0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1021\/op4001143","article-title":"High-shear rotor\u2013stator wet milling for drug substances: expanding capability with improved scalability","volume":"17","author":"Harter","year":"2013","journal-title":"Org Process Res Dev"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.019_bib0021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1205\/fbio.82.4.311.56401","article-title":"Apparatus for emulsion production in small scale and under controlled shear conditions","volume":"82","author":"Adler-Nissen","year":"2004","journal-title":"Food Bioprod Process"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2007.12.017","article-title":"Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation","volume":"355","author":"Dong","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0023","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.xphs.2017.07.001","article-title":"Producing amorphous solid dispersions via co-precipitation and spray drying: impact to physicochemical and biopharmaceutical properties","volume":"107","author":"Mann","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.12.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-022-03308-9","article-title":"Assessing the interrelationship of microstructure, properties, drug release performance, and preparation process for amorphous solid dispersions via noninvasive imaging analytics and material characterization","author":"Jia","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2022.12.019_bib0025","article-title":"High bulk-density amorphous dispersions to enable direct compression of reduced tablet size amorphous dosage units","author":"Frank","year":"2022","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2022.12.019_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122017","article-title":"Optimizing solvent selection and processing conditions to generate high bulk-density, co-precipitated amorphous dispersions of posaconazole","volume":"13","author":"Frank","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.xphs.2022.12.019_bib0027","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1021\/acs.molpharmaceut.0c00198","article-title":"Recent advances in co-processed APIs and proposals for enabling commercialization of these transformative technologies","volume":"17","author":"Schenck","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2022.12.019_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.colcom.2017.02.002","article-title":"Design principles for the formation of ordered patterns in binary mixtures of colloidal particles on spherical droplets","volume":"17","author":"Fortuna","year":"2017","journal-title":"Colloids Interface Sci Commun"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0032-5910(75)80021-0","article-title":"Ordered mixing: a new concept in powder mixing practice","volume":"11","author":"Hersey","year":"1975","journal-title":"Powder Technol"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.019_bib0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/acs.molpharmaceut.1c00481","article-title":"Balancing solid-state stability and dissolution performance of lumefantrine amorphous solid dispersions: the role of polymer choice and drug\u2013polymer interactions","volume":"19","author":"Hiew","year":"2022","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2022.12.019_bib0031","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the dissolution mechanism of ritonavir\u2013copovidone amorphous solid dispersions: importance of congruent release for enhanced performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2022.12.019_bib0032","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1021\/acs.molpharmaceut.9b01025","article-title":"Insights into the dissolution behavior of ledipasvir\u2013copovidone amorphous solid dispersions: role of drug loading and intermolecular interactions","volume":"16","author":"Que","year":"2019","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.019_bib0033","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.molpharmaceut.9b01272","article-title":"Congruent release of drug and polymer from amorphous solid dispersions: insights into the role of drug-polymer hydrogen bonding, surface crystallization, and glass transition","volume":"17","author":"Saboo","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2022.12.019_bib0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.039","article-title":"Congruent release of drug and polymer: a \u201csweet spot\u201d in the dissolution of amorphous solid dispersions","volume":"298","author":"Saboo","year":"2019","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.xphs.2022.12.019_bib0035","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1021\/acs.molpharmaceut.1c00055","article-title":"Drug release and nanodroplet formation from amorphous solid dispersions: insight into the roles of drug physicochemical properties and polymer selection","volume":"18","author":"Yang","year":"2021","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2022.12.019_bib0036","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/cg301679h","article-title":"Liquid\u2013liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: implications for solubility enhancing formulations","volume":"13","author":"Ilevbare","year":"2013","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.019_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/powders1020008","article-title":"A combined isolation and formulation approach to convert nanomilled suspensions into high drug-loaded composite particles that readily reconstitute","volume":"1","author":"Coelho","year":"2022","journal-title":"Powders"},{"key":"10.1016\/j.xphs.2022.12.019_bib0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2022.09.056","article-title":"Combining drug salt formation with amorphous solid dispersions \u2013 a double edged sword","volume":"352","author":"Hiew","year":"2022","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.019_bib0039","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/aic.10329","article-title":"Facilitated diffusion in the dissolution of carboxylic polymers","volume":"51","author":"Nguyen","year":"2005","journal-title":"AIChE J"},{"issue":"2","key":"10.1016\/j.xphs.2022.12.019_bib0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/mp500660m","article-title":"Drug\u2013polymer\u2013water interaction and its implication for the dissolution performance of amorphous solid dispersions","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2022.12.019_bib0041","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2018.02.005","article-title":"Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion","volume":"540","author":"Bhardwaj","year":"2018","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2022.12.019_bib0042","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1021\/acs.molpharmaceut.0c00798","article-title":"Water-induced phase separation of spray-dried amorphous solid dispersions","volume":"17","author":"Li","year":"2020","journal-title":"Mol Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922005834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922005834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:42:55Z","timestamp":1758361375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922005834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022354922005834"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.12.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}